Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child

Congenital optic nerve abnormalities may rarely cause choroidal neovascularization (CNV). This case report summarizes the clinical and therapeutic outcomes of a 7-year-old boy with unilateral CNV secondary to morning glory syndrome associated with acute visual acuity loss. The patient was successful...

Full description

Saved in:
Bibliographic Details
Published in:Saudi journal of ophthalmology 2016-04, Vol.30 (2), p.140-143
Main Authors: Özkaya, Abdullah, Yilmaz, Ihsan, Alkin, Zeynep, Karakucuk, Yalcin, Yazici, Ahmet Taylan
Format: Article
Language:English
Subjects:
Case Report
Choroidal neovascularization
Morning glory syndrome
Ranibizumab
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Congenital optic nerve abnormalities may rarely cause choroidal neovascularization (CNV). This case report summarizes the clinical and therapeutic outcomes of a 7-year-old boy with unilateral CNV secondary to morning glory syndrome associated with acute visual acuity loss. The patient was successfully treated with a single intravitreal ranibizumab injection. One month after the injection the visual acuity increased and optic coherence tomography (OCT) showed a decrease in the intraretinal fluid around the CNV. The patient was then called for monthly follow-up visits. No further treatment was needed for the next 12months after the first treatment. There was no complication related to the injection.
ISSN:1319-4534
DOI:10.1016/j.sjopt.2016.02.004